COVID-19-associated hypertriglyceridemia and impact of treatment
Description
CONCLUSION: Hypertriglyceridemia associated with COVID-19 did not increase death rate, but prolonged time to death and length of stay. Treating hypertriglyceridemia did not translate into improvement in clinical outcomes including mortality.
